Skip to main content
Log in

A Survey of the Interactions Between Psychiatry Residency Programs and the Pharmaceutical Industry

  • Original Article
  • Published:
Academic Psychiatry Aims and scope Submit manuscript

Abstract

Objective: The authors report a survey of the American Association of Directors of Psychiatry Residency Training (AADPRT) on interactions between the pharmaceutical industry and psychiatry residency programs. Methods: American Association of Directors of Psychiatry Residency Training membership was anonymously surveyed by e-mail and by paper distribution at the 2002 annual meeting. Results: Twenty-seven percent of AADPRT members participated. Lunches for residents were the most common interaction, reported by 93% of programs, nearly all of which permitted literature and gifts to be distributed. Only 4% required faculty to be present. Retreats (27%) and travel funds (34%) were sponsored less frequently. One third of programs had written policies governing these interactions, but half of respondents did not know if their parent institutions had such policies. A minority of programs (40%) had formal didactic instruction for residents on this topic. Support for more information, direction, and teaching was widespread. Conclusions: The authors recommend more structured teaching and the establishment of formal program and institutional policies to govern these interactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hodges B: Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns, and clerks. CMAJ 1995; 153: 553–559

    CAS  PubMed Central  PubMed  Google Scholar 

  2. American Medical Association, Council of Ethical and Judicial Affairs: Gifts to physicians from industry. JAMA 1991; 265: 501

    Article  Google Scholar 

  3. American Medical Association, Committee on Education: Ethical guidelines for gifts to physician from industry. Available at http://www.ama-assn.org/ama/pub/category/5689.html. Accessibility verified 3/8/04.

  4. American College of Graduate Medical Education: Principles to guide the relationship between graduate medical education and industry. ACGME 9/10/02. Available at: http://www.acgme.org/New/GMEGuide.doc. Accessibility verified on 3/2/04.

  5. Steinman MA: Gifts to physicians in the consumer marketing era. JAMA 2000; 284: 2243

    Article  CAS  PubMed  Google Scholar 

  6. Santana S: AAMC Executive Council sets guidelines on industry marketing to residents. AAMC Reporter, April 2003. Available at: http://www.aamc.org/newsroom/reporter/april03/executivecouncil.htm. Accesibility verified on 3/3/04.

  7. Ferguson RP, Rhim E, Belizaire W, et al: Encounters with pharmaceutical sales representatives among practicing internists. Am J Med 1999; 107: 149–152

    Article  CAS  PubMed  Google Scholar 

  8. Sergeant MD, Hodgetts PG, Godwin M, et al: Interactions with the pharmaceutical industry. CMAJ 1966; 155: 1243–1248

    Google Scholar 

  9. Reeder M, Dougherty J, White LJ: Pharmaceutical representatives and emergency medicine residents. Ann Emerg Med 1993; 22: 105–108

    Article  Google Scholar 

  10. Pharmaceutical Research and Manufacturers of America: PhRMA code on interactions with healthcare professionals. Available at http://www.phrma.org. Accessibility verified 3/8/04.

  11. Brotzman GL, Mark DH: Policies regulating the activities of pharmaceutical representatives in residency programs. J Fam Pract 1992; 34: 154–157

    Google Scholar 

  12. Mahood S, Zagozeski C, Bradel T, et al: Pharmaceutical policies in Canadian family medicine training: survey of residency programs. Can Fam Physician 1997; 43: 1947–1951

    CAS  PubMed Central  PubMed  Google Scholar 

  13. Steinman MA, Shilpak MG, McPhee SJ: Of principles and pens: attitudes of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001; 110: 551–557

    Article  CAS  PubMed  Google Scholar 

  14. Lichstein PR, Turner RC, O’Brien K: Impact of pharmaceutical company representatives on internal medicine residency programs: a survey of residency program directors. Arch Intern Med 1992; 152: 1009–1013

    Article  CAS  PubMed  Google Scholar 

  15. Reeder M, Dougherty J, White LJ: Pharmaceutical representatives and emergency medicine residents. Ann Emerg Med 1993; 22: 105–108

    Article  Google Scholar 

  16. Keim SM, Sanders AB, Witzke DB, et al: Beliefs and practices of emergency medicine faculty and residents regarding professional interactions with the biomedical industry. Ann Emerg Med 1993; 22: 1576–1581

    Article  CAS  PubMed  Google Scholar 

  17. Rosack J: Residents want education on interacting with drug industry. Psychiatr News 2001; 36: 18

    Google Scholar 

  18. Sierles FS, Magrane D: Psychiatry clerkship directors: who they are, what they do, and what they think. Psychiatr Q 1996; 67: 153–162

    Article  CAS  PubMed  Google Scholar 

  19. Vinson DC, McCandless B, Hosokawa MC: Medical students’ attitudes toward pharmaceutical marketing: possibilities for change. Fam Med 1993; 25: 31–33

    CAS  PubMed  Google Scholar 

  20. Wilkes M, Hoffman J: An innovative approach to educating medical students about pharmaceutical promotion. Acad Med 2001; 76: 1271–1277

    Article  CAS  PubMed  Google Scholar 

  21. Brotzman G, Mark D: The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med 1993; 8: 130–134

    Article  CAS  PubMed  Google Scholar 

  22. Hopper JA, Speece MW, Musial JL: Effects of an educational intervention on residents’ knowledge and attitudes toward interactions with pharmaceutical representatives. J Gen Intern Med 1997; 12: 639–642

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. McCormick BB, Tomlinson G, Brill-Edwards P, et al: Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA 2001; 286: 1994–1999

    Article  CAS  PubMed  Google Scholar 

  24. Shaugnessy AF, Slawson DC, Bennett JH: Teaching information mastery: evaluating information provided by pharmaceutical representatives. Fam Med 1995; 27: 581–585

    Google Scholar 

  25. Brodkey A, Sierles FS: Psychiatry education and the pharmaceutical industry: issues and responses. Teach Learn Med 2003;15: 68–69

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christopher K. Varley M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Varley, C.K., Jibson, M.D., McCarthy, M. et al. A Survey of the Interactions Between Psychiatry Residency Programs and the Pharmaceutical Industry. Acad Psychiatry 29, 40–46 (2005). https://doi.org/10.1176/appi.ap.29.1.40

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1176/appi.ap.29.1.40

Keywords

Navigation